Conversion to belatacept after lung transplantation: Report of 10 cases.
Olivier BrugièreAlexandre ValléeQuentin RaimbourgMarie-Noelle PeraldiSylvie Colin de VerdièreLaurence BeaumontAbdulmonem HamidMathilde ZrounbaAntoine RouxClément PicardFrançois ParquinMatthieu GlorionJulie OniszczukAlexandre HertigHervé MalVincent BunelPublished in: PloS one (2023)
Early conversion to CNI-free belatacept-based IS improved renal function in this series but was counterbalanced by a high incidence of recurrent ACR, including life-threatening episodes. Other studies are needed to better determine the indications for its use after LTx, possibly with lower immunological risk IS regimens, such as CNI-sparing belatacept.